Market Watch Jounce stock bounces more than 70% after Gilead acquires immunotherapy drug Jounce Therapeutics Inc. JNCE, -6.66% shares jumped more than 70% in after-hours trading Tuesday, following an announcement that Gilead Sciences Inc. GILD, +0.31% would completely…breakingnow_w51jcqDecember 27, 2022
